DHB Dhb Industries, Inc.

WESTBURY, N.Y., Jan. 24 /PRNewswire-FirstCall/ -- DHB Industries Inc. (AMEX:DHB) today announced a directive from its board authorizing the Company to purchase an additional 3 million shares of its common stock in the open market in accordance with applicable law, from time to time, at its discretion. Previously, the Company announced that, in accordance with the November 2005 amendment of its Credit Facility with LaSalle Business Credit, the Company was authorized to repurchase in the open market up to three million shares of its common stock, provided there was no event of default at the time of repurchase and that no more than $9 million of the purchase price was funded through the Credit Facility. The Company has repurchased approximately 2,090,000 shares in the open market at an average price of $4.04 without increasing the outstanding balance of the Company's Credit Facility. Therefore, the Company can still repurchase approximately 3,910,000 shares in the open market as long at the amount funded through the Credit Facility does not exceed $9 million. About DHB Industries Inc. DHB Industries Inc.'s Armor Group is in the protective body armor industry. Its highly recognized subsidiaries, Point Blank Body Armor Inc. (http://www.pointblankarmor.com/) and Protective Apparel Corporation of America (PACA) (http://www.pacabodyarmor.com/) are focused on the design, manufacture, and distribution of bullet resistant body armor for military, law enforcement, and corrections in the U.S. and worldwide. DHB Armor Group's customers include the U.S. Army, Air Force, Navy, Marines, Coast Guard, Secret Service, FBI, DEA, ATF, NATO, U.S. Marshals, the NYC Police Department, the LA Police Department, and the California Highway Patrol. DHB Sports Group produces and markets a comprehensive line of athletic supports and braces which are merchandised through national superstore chains including Wal-Mart, Walgreen's, and Kerr Drugs as well as private label distributors such as Meijer, Amerisource, Cardinal Health, and Chain Drug Marketing Association (CDMA). Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The Statements which are not historical facts contained in this press release are forward-looking statements, which are based largely on the Company's expectations and are subject to various business risks and uncertainties, certain of which are beyond the Company's control. Words such as "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," variations of such words, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are only predictions that speak as of the date hereof and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in our reports on file with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date hereof. We undertake no obligation to revise or update publicly any forward-looking statements to reflect any change in the expectations of our management with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Company Contact: Dawn Schlegel, CFO 516/997-1155 FCMN Contact: dschlegel@dhbt.com DATASOURCE: DHB Industries Inc. CONTACT: Dawn Schlegel, CFO of DHB Industries Inc., +1-516-997-1155, or Web site: http://www.dhbindustries.com/

Copyright